"Doliprane is our baby, let's keep it," say employees at Sanofi's Lisieux production site, where some of the staff strike over the planned sale of healthcare giant's consumer healthcare division, Opella, which markets Doliprane, to US investors. "The CGT will raise the issue of nationalisation of the site to guarantee the economic sovereignty of this country," says Allan Bertu, the general secretary of the CGT Union in the department of Calvados. IMAGES AND SOUNDBITES (COMPLETES VIDI36KA4P8_EN)